Surgical Site Infection
Surgical Site Infection - Related Videos
08:33
Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus
0 Views •
Cited by 14 •
2011
The transplantation of mouse neural stem cells (NSCs) into the spinal cords of mice with established demyelination is detailed. The preparation of NSCs, the laminectomy of thoracic vertebra 9 (T9), and transplantation of NSCs is outlined along with the pre- and post-operative care of the mice.
04:53
Surgical Management of Meatal Stenosis with Meatoplasty
0 Views •
Cited by 13 •
2010
Meatoplasty, surgical management of meatal stenosis.
12:30
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
0 Views •
Cited by 108 •
2013
The larva of the wax moth Galleria mellonella was recently established as an in vivo model to study Legionella pneumophila infection. Here, we demonstrate fundamental techniques to characterize the pathogenesis of Legionella in the larvae, including inoculation, measurement of bacterial virulence and replication as well as extraction and analysis of infected hemocytes.
07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
0 Views •
Cited by 3 •
2016
This manuscript describes the use of a bioluminescent strain of African trypanosomes to enable the tracking of late stage infection and demonstrates how in vivo live imaging can be used to visualize infections within the central nervous system in real-time.
11:18
Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens
0 Views •
Cited by 234 •
2012
Transparent zebrafish embryos have proved useful model hosts to visualize and functionally study interactions between innate immune cells and intracellular bacterial pathogens, such as Salmonella typhimurium and Mycobacterium marinum. Micro-injection of bacteria and multi-color fluorescence imaging are essential techniques involved in the application of zebrafish embryo infection models.
FAQs
Microorganisms can enter the operative site or multiply there when surgical tissue has been damaged or exposed to contamination. The local environment becomes more vulnerable when blood flow is impaired, because affected tissue may have reduced capacity to support healing. These interacting conditions help explain why infection risk depends on both microbial exposure and the condition of the surgical site.
Risk rises when tissue damage, contamination, or impaired blood flow are present alongside patient factors such as diabetes or weakened immunity. These influences can act together rather than independently, increasing vulnerability at the operative site. Recognizing the combination helps clinicians interpret postoperative changes and identify patients who may require closer observation during recovery.
Evaluation should consider changes in wound appearance, increasing pain, drainage, fever, and systemic signs. These findings provide complementary information: local changes may indicate involvement near the incision, while fever or other systemic features may suggest a broader response. Clinicians can supplement this assessment with microbiological testing or imaging when the clinical picture requires further clarification.
Prevention combines sterile technique, appropriate antimicrobial use, and careful wound care rather than relying on one measure alone. Sterile practice limits contamination, antimicrobial decisions address microbial risk when appropriate, and wound care supports continued observation and protection of the operative site. Together, these measures target different points in the development and progression of infection.
Management depends on timely recognition followed by clinical assessment, microbiological testing or imaging when indicated, and appropriate treatment. Wound care remains part of the response, while antimicrobial use must be appropriate to the clinical situation. Prompt action matters because untreated infection can delay healing, increase complications, and prolong hospitalization.
Surveillance tracks surgical site infection as an outcome and supports efforts to improve clinical care. By monitoring wound findings, treatment needs, complications, and hospitalization patterns, clinical teams can identify problems that warrant attention and evaluate whether prevention and management practices are achieving better results. This makes surveillance relevant to both individual patient recovery and broader quality improvement.